Nkem Azu

Nkem Azu

Auto-generated profile, based on publicly available information

Nkem Azu

Mayo Clinic

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2015 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
SSShishir Shishodia
Shishir Shishodia
NANkem Azu
Nkem Azu
JRJason A. Rosenzweig
Jason A. Rosenzweig
DJDesiree A. Jackson
Desiree A. Jackson
Guggulsterone [4, 17(20)-pregnadiene-3, 16-dione] is a plant sterol derived from the gum resin of the tree Commiphora wightii. The gum resin of the guggul tree has been used in traditional medicine for centuries to treat obesity, liver disorders, internal tumors, malignant sores, ulcers, urinary complaints, intestinal worms, leucoderma, sinus, edema and sudden paralytic seizures. Guggulsterone has been shown to modulate the nuclear receptors, farnesoid X receptor, pregnane X receptor, CYP 2b10 gene expression, and the bile salt export pump for cholesterol elimination. Recent research indicates that the active components of gum guggul, E- and Zguggulsterone have the potential to both prevent and treat cancers. Guggulsterone inhibits the growth of a wide variety of tumor cells and induces apoptosis through down regulation of antiapoptotic gene products (IAP1, xIAP, Bfl-1/A1, Bcl-2, cFLIP, and survivin), modulation of cell cycle proteins (cyclin D1 and c-Myc), activation of caspases, inhibition of Akt, and activation of JNK. Guggulsterone modulates the expression of gene products involved in metastasis (MMP-9, COX-2, and VEGF) of tumor cells. Guggulsterone mediates gene expression through the modulation of several transcription factors, including NF-κB, STAT3, C/EBPα, androgen receptor, and glucocorticoid receptors. This review describes the anti-cancer properties, molecular targets, and the apoptotic effects of guggulsterone.

24 August 2018 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
MBMariam Bado
Mariam Bado
DKDjene Keita
Djene Keita
NANkem Azu
Nkem Azu
SSShishir Shishodia
Shishir Shishodia
JRJason A. Rosenzweig
Jason A. Rosenzweig

20 December 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
ACAngela M. Crist
Angela M. Crist
KHKelly M. Hinkle
Kelly M. Hinkle
XWXue Wang
Xue Wang
CMChristina M. Moloney
Christina M. Moloney
BMBillie J. Matchett
Billie J. Matchett
MMMelissa E. Murray
Melissa E. Murray
Summary: Selective vulnerability is a central concept to the myriad of devastating neurodegenerative disorders. Although hippocampus and cortex are selectively vulnerable in Alzheimer’s disease (AD), the degree of involvement lies along a spectrum that we previously defined as AD subtypes revealing distinct clinical correlates. To operationalize heterogeneity of disease spectrum, we classified corticolimbic patterns of neurofibrillary tangles to capture extreme and representative phenotypes. We combined bulk RNA sequencing with digital pathology to examine hippocampal vulnerability in AD. Using a multidisciplinary approach, we uncovered disease-relevant hippocampal gene expression changes. Biological relevance was prioritized using machine learning and several levels of human validation. This resulted in five genes highly predictive of neuropathologically diagnosed AD: SERPINA5, RYBP, SLC38A2, FEM1B , and PYDC1 . Deeper investigation revealed SERPINA5 to be a novel tau binding partner that may represent a “tipping point” in the dynamic maturity of neurofibrillary tangles. Our study highlights the importance of embracing heterogeneity of the human brain to yield promising gene candidates as exampled by SERPINA5 .